Atlas Trials

MAP to Provide Access to Nilotinib, for Patients With HES

Clinical trial NCT04498871 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT04498871
Sponsor
Novartis Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Hypereosinophilic Syndrome (HES)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.